Our top pick for
Amplify Energy Corp is an oil & gas e&p business based in the US. Amplify Energy shares (AMPY) are listed on the NYSE and all prices are listed in US Dollars. Amplify Energy employs 189 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$4.02|
|52-week range||$0.62 - $5.78|
|50-day moving average||$3.98|
|200-day moving average||$3.55|
|Wall St. target price||$6.20|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-2.91|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||6.63%|
|1 month (2021-09-20)||4.96%|
|3 months (2021-07-23)||26.81%|
|6 months (2021-04-23)||66.12%|
|1 year (2020-10-23)||392.04%|
|2 years (2019-10-23)||-44.93%|
|3 years (2018-10-23)||8.13|
|5 years (2016-10-19)||N/A|
Valuing Amplify Energy stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amplify Energy's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Amplify Energy's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $81.7 million.
The EBITDA is a measure of a Amplify Energy's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$261.7 million|
|Gross profit TTM||$60.9 million|
|Return on assets TTM||-14.91%|
|Return on equity TTM||-2633.39%|
|Market capitalisation||$139.1 million|
TTM: trailing 12 months
There are currently 956,008 Amplify Energy shares held short by investors – that's known as Amplify Energy's "short interest". This figure is 7.8% down from 1.0 million last month.
There are a few different ways that this level of interest in shorting Amplify Energy shares can be evaluated.
Amplify Energy's "short interest ratio" (SIR) is the quantity of Amplify Energy shares currently shorted divided by the average quantity of Amplify Energy shares traded daily (recently around 382403.2). Amplify Energy's SIR currently stands at 2.5. In other words for every 100,000 Amplify Energy shares traded daily on the market, roughly 2500 shares are currently held short.
However Amplify Energy's short interest can also be evaluated against the total number of Amplify Energy shares, or, against the total number of tradable Amplify Energy shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Amplify Energy's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 Amplify Energy shares in existence, roughly 30 shares are currently held short) or 0.0273% of the tradable shares (for every 100,000 tradable Amplify Energy shares, roughly 27 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Amplify Energy.
Find out more about how you can short Amplify Energy stock.
We're not expecting Amplify Energy to pay a dividend over the next 12 months.
Amplify Energy's shares were split on a 1:10 basis on 3 August 2015. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Amplify Energy shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Amplify Energy shares which in turn could have impacted Amplify Energy's share price.
Over the last 12 months, Amplify Energy's shares have ranged in value from as little as $0.6201 up to $5.78. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amplify Energy's is 4.7899. This would suggest that Amplify Energy's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Amplify Energy Corp. engages in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's properties consist of operated and non-operated working interests in producing and undeveloped leasehold acreage, as well as working interests in identified producing wells located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana, and Eagle Ford. As of December 31, 2020, it had total estimated proved reserves of approximately 113. 8 million barrels of oil equivalent; and 2,448 gross producing wells. Amplify Energy Corp. was founded in 2011 and is based in Houston, Texas.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.